| Guidance Title | Issue Date | FDA Organization | Topics | Status |
|---|---|---|---|---|
| Institutional Review Boards Frequently Asked Questions: Guidance for Institutional Review Boards and Clinical Investigators |
2025-02-05 | OC\Office of the Chief Medical Officer\Office of Clinical Policy |
Good Clinical Practice (GCP), Pediatric Product Development |
Final |
| Evaluation of Sex Differences in Clinical Investigations: Guidance for Industry |
2025-01-20 | OC\Office of the Chief Medical Officer\Office of Clinical Policy |
Good Clinical Practice (GCP) |
Final |
| Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry |
2025-01-15 | CBER | Blood, Blood Products | Draft |